The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.00
Bid: 27.00
Ask: 27.15
Change: 0.00 (0.00%)
Spread: 0.15 (0.556%)
Open: 27.05
High: 27.35
Low: 26.60
Prev. Close: 27.00
SHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

4 May 2023 07:00

RNS Number : 3411Y
SIG PLC
04 May 2023
 

4 May 2023

SIG plc Trading Update

Trading in line with expectations

 

SIG plc ("SIG", or "the Group"), a leading supplier of specialist insulation and building products across Europe, today issues a trading update for 1 January to 30 April 2023 ("the period"), in advance of its Annual General Meeting, which is being held later this morning.

 

Key points

· Trading in the period in line with management expectations

· Group like-for-like1 ("LFL") sales growth of 1%, with revenues of £924m

· Results reflect challenging market conditions, more than offset by input price inflation

· Solid sales growth from France, Germany, and UK Interiors

· Group's 2023 full year outlook unchanged

 

Trading Summary

Group LFL sales were up 1% in the period compared to prior year. Reported Group revenues were 7% higher in the period, including c.3% from acquisitions, together with c.3% in aggregate from movements on working days and exchange rates. Market conditions remain challenging and Group volumes were lower, as expected. This was more than offset by a continued positive tailwind from input price inflation.

 

The overall impact of inflation is estimated to have added c.11% to Group growth over the period. As expected, price inflation has moderated since H2 2022, despite further price increases in early 2023, as we annualise some of the significant prior year price increases.

 

1 January to 30 April 2023 Sales

%

LFL growth vs 2022

£'m

UK Interiors

5%

249

UK Exteriors

(3)%

142

UK

 

2%

391

France Interiors

3%

76

France Exteriors

7%

165

Germany

2%

153

Poland

(13)%

68

Benelux

11%

40

Ireland

(17)%

31

EU

 

1%

533

Group

 

1%

924

 

Our French, German and UK Interiors businesses continued to deliver solid sales growth. The UK Exteriors business saw some further softening in the RMI end-market, continuing the trend seen in the latter part of 2022. Volumes and market conditions have been notably weaker in Poland and Ireland in recent weeks, with the former also coming up against especially strong prior year comparators.

 

The Group has continued to make progress on its strategic initiatives, while managing challenging market conditions. During 2023 our operational priorities include active product category management to develop product mix and margin over time and leveraging prior year investment in new branches and strategic relocations.

 

Outlook

Our outlook for FY23 remains unchanged. As set out in our FY22 results on 8 March 2023, we expect weaker and uncertain demand conditions to prevail during 2023, offset by a continued tailwind from input price inflation, albeit the latter will continue to moderate further this year.

 

We continue to focus on operational agility, productivity, and discipline in 2023.  We remain confident in our ability to harness the strong momentum in the business and further improve our market positions, and to continue to improve our profitability when market conditions recover.

 

As a European market leader in the supply of specialist insulation, and with 80% of the Group's sales covering insulation and the wider building envelope, we are well-positioned to benefit from long-term structural growth drivers, notably sustainable construction and decarbonisation of buildings. Notwithstanding short-term market weakness, we expect to benefit from long-term growth in demand for the Group's products across our pan-European network of branches. 

 

Following the arrival of Gavin Slark in February 2023 as new CEO, the Group continues to review the strategic and operational priorities in each of our operating companies and the roadmap towards our medium term 5% operating margin target. 

 

H1 Results date

We will publish our H1 2023 results on 8 August 2023 and will hold a presentation and conference call for analysts and investors at 10.00am (GMT) on that date.

 

1. Like-for-like is defined as sales per working day in constant currency, excluding completed acquisitions and disposals

 

Contacts

SIG plc

 

+44 (0) 114 285 6300 / ir@sigplc.com

Gavin Slark

Ian Ashton

Chief Executive Officer

Chief Financial Officer

 

Sarah Ogilvie

Head of Investor Relations

FTI Consulting

 

+44 (0) 20 3727 1340

Richard Mountain

Peel Hunt LLP - Joint broker to SIG

+44 (0) 20 7418 8900

Mike Bell / Charles Batten

 

 

Investec Bank plc - Joint broker to SIG

+44 (0) 20 7597 5970

Bruce Garrow / David Anderson

 

LEI: 213800VDC1BKJEZ8PV53

 

Cautionary Statement

This document contains certain forward-looking statements concerning the Group's business, financial condition, results of operations and certain Group's plans, objectives, assumptions, projections, expectations or beliefs with respect to these items. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as 'anticipates', 'aims', 'due', 'could', 'may', 'will', 'would', 'should', 'expects', 'believes', 'intends', 'plans', 'potential', 'targets', 'goal', 'forecasts' or 'estimates' or similar expressions or negatives thereof.

 

Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the Group's actual financial condition, performance and results to differ materially from the plans, goals, objectives and expectations set out in the forward-looking statements included in this document.

 

All written or verbal forward-looking statements, made in this document or made subsequently, which are attributable to the Group or any persons acting on its behalf are expressly qualified in their entirety by the factors referred to above. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements. No assurance can be given that the forward-looking statements in this document will be realised; actual events or results may differ materially as a result of risks and uncertainties facing the Group. Subject to compliance with applicable law and regulation, the Group does not intend to update the forward-looking statements in this document to reflect events or circumstances after the date of this document and does not undertake any obligation to do so.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUOUWROOUVRAR
Date   Source Headline
12th Apr 20244:01 pmRNSDirector/PDMR Shareholding
4th Apr 202410:12 amRNSDirector/PDMR Shareholding
25th Mar 202410:21 amRNSNotice of AGM
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 202410:12 amRNSDirector/PDMR Shareholding
5th Mar 202412:14 pmRNSAnnual Financial Report
5th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
9th Jan 20247:00 amRNS2023 Full Year Trading Update
1st Dec 20235:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSCapital Markets Event
13th Nov 20239:00 amRNSNotice of Capital Markets Event
13th Oct 20233:51 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ3 Trading Update
25th Sep 20233:56 pmRNSDirectorate Change
9th Aug 20234:58 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSHolding(s) in Company
11th Jul 20234:06 pmRNSHolding(s) in Company
11th Jul 202310:58 amRNSHolding(s) in Company
10th Jul 202311:09 amRNSHolding(s) in Company
5th Jul 20233:15 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSH1 Trading Update
4th May 20232:32 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
31st Mar 202312:47 pmRNSHolding(s) in Company
27th Mar 202310:30 amRNSNotice of AGM
13th Mar 20233:49 pmRNSDirector/PDMR Shareholding
13th Mar 20233:39 pmRNSDirector/PDMR Shareholding
13th Mar 202310:36 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSDirector/PDMR Shareholding
8th Mar 20231:20 pmRNSAnnual Financial Report
8th Mar 20237:01 amRNSDirectorate Changes
8th Mar 20237:00 amRNSFull year results for the year ended 31 Dec 2022
27th Feb 202311:20 amRNSDirector Declaration
1st Feb 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding
8th Apr 20223:28 pmRNSDirector/PDMR Shareholding
8th Apr 20223:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.